Viewing Study NCT00323804


Ignite Creation Date: 2025-12-24 @ 9:19 PM
Ignite Modification Date: 2025-12-25 @ 7:07 PM
Study NCT ID: NCT00323804
Status: COMPLETED
Last Update Posted: 2014-09-04
First Post: 2006-05-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Sponsor: ANRS, Emerging Infectious Diseases
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module